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The receptor Flt3 and its ligand Flt3L are both critical for dendritic cell (DC) development, but DC deficiency is more severe 
in Flt3l−/− mice than in Flt3−/− mice. This has led to speculation that Flt3L binds to another receptor that also supports DC 
development. However, we found that Flt3L administration does not generate DCs in Flt3−/− mice, arguing against a second 
receptor. Instead, Flt3−/− DC progenitors matured in response to macrophage colony–stimulating factor (M-CSF) or stem 
cell factor, and deletion of Csf1r in Flt3−/− mice further reduced DC development, indicating that these cytokines could 
compensate for Flt3. Surprisingly, Flt3−/− DC progenitors displayed enhanced M-CSF signaling, suggesting that loss of Flt3 
increased responsiveness to other cytokines. In agreement, deletion of Flt3 in Flt3l−/− mice paradoxically rescued their severe 
DC deficiency. Thus, multiple cytokines can support DC development, and the discrepancy between Flt3−/− and Flt3l−/− mice 
results from the increased sensitivity of Flt3−/− progenitors to these cytokines.
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Introduction
Dendritic cells (DCs) are immune cells with critical functions 
in both the innate and adaptive immune responses that develop 
from hematopoietic progenitor cells (Liu et al., 2007; Mildner 
and Jung, 2014). The earliest committed progenitor with DC fate 
potential is the macrophage/DC progenitor (MDP; Fogg et al., 
2006; Auffray et al., 2009), which develops into a common DC 
progenitor (CDP) that can give rise to plasmacytoid DCs (pDCs) as 
well as the classical DC (cDC) subsets, cDC1 and cDC2 (Naik et al., 
2007; Onai et al., 2007). Committed cDC progenitors restricted to 
only the cDC1 or the cDC2 lineage have recently been identified 
in mice (Grajales-Reyes et al., 2015; Schlitzer et al., 2015) and in 
humans (Breton et al., 2015; Lee et al., 2015; See et al., 2017).
The development of DCs is dependent on the class III receptor 
tyrosine kinase (RTK) Fms-like tyrosine kinase 3 (Flt3) and its 
ligand Flt3L (McKenna et al., 2000; Waskow et al., 2008). Flt3 
was first identified as a gene enriched in hematopoietic stem 
cells that encoded a protein homologous to the receptor c-Kit 
(Matthews et al., 1991). It was later recognized to be expressed on 
mature DCs and their progenitors as well (Miller et al., 2012). Flt3 
shares structural properties and downstream signaling pathways 
with c-Kit and CSF1R, other members of the class III RTK family 
that are also expressed by committed DC progenitors (Onai et al., 
2007; Verstraete and Savvides, 2012; Grajales-Reyes et al., 2015). 
The ligand for Flt3, Flt3L, was subsequently cloned and found 
to induce proliferation in early bone marrow (BM) progenitors 
(Lyman et al., 1993). Later, a role for Flt3L in DC homeostasis 
was uncovered from the expansion of DCs in mice and humans 
who were administered this cytokine (Maraskovsky et al., 1996, 
2000). Furthermore, treatment of BM progenitors in vitro with 
Flt3L also supports the development of mature DCs (Brasel et 
al., 2000; Naik et al., 2005), and Flt3+ progenitors preferentially 
gave rise to DCs in vivo (D’Amico and Wu, 2003). Finally, genetic 
inactivation of the Flt3 (Mackarehtschian et al., 1995) or Flt3l 
(McKenna et al., 2000) genes in mice was observed to decrease 
the numbers of DCs (McKenna et al., 2000; Waskow et al., 2008), 
confirming their importance in DC homeostasis.
These original studies of Flt3−/− and Flt3l−/− mice surprisingly 
appeared to find DC deficiencies of varying severity in these two 
strains. Flt3l−/− mice analyzed between 5 and 14 wk of age had a 4- 
to 10-fold reduction in splenic CD8α– DCs and a 6- to 14-fold reduc-
tion in splenic CD8α+ DCs (McKenna et al., 2000). Meanwhile, an 
analysis of Flt3−/− mice found that although all DCs were reduced 
by 85% at 2 wk of age, they were reduced by only 43% (cDCs) or 
65% (pDCs) at 9 wk of age (Waskow et al., 2008). Another study 
that examined both strains between 8 and 12 wk of age similarly 
found more severe reductions in CD8α+ DCs and CD11b+ DCs in 
Flt3l−/− mice compared with Flt3−/− mice (Ginhoux et al., 2009). 
This discrepancy has also been noted in the development of 
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pre-pro-B cells, with Flt3l−/− mice demonstrating a severe reduc-
tion in this population, whereas Flt3−/− mice had only a twofold 
reduction (Mackarehtschian et al., 1995; Sitnicka et al., 2002, 
2003; Nagasawa, 2006). However, no study has directly com-
pared Flt3−/− mice with Flt3l−/− mice over time, so it is unknown 
whether the defects caused by Flt3L deficiency improve with age, 
as with Flt3 deficiency, or whether Flt3−/− mice and Flt3l−/− mice 
simply have distinct phenotypes. Nevertheless, these apparent 
discrepancies in phenotypes have led to suggestions that Flt3L 
could act on a second receptor other than Flt3 to support DC or B 
cell development, explaining the more severe defects in Flt3l−/− 
mice (Nagasawa, 2006; Helft et al., 2010; Satpathy et al., 2011; 
Moore and Anderson, 2013; Tsapogas et al., 2017).
Cytokines such as Flt3L can play supportive and instruc-
tive roles in the development of hematopoietic lineages (Enver 
et al., 1998; Metcalf, 1998), and the actions of a given cytokine 
may depend upon the progenitor stage and cell type it acts upon 
(Rieger et al., 2009; Mossadegh-Keller et al., 2013). For DCs, 
an instructive role for Flt3 was suggested by the redirection of 
megakaryocyte-erythrocyte progenitors (MEPs) toward DC 
fate upon forced Flt3 overexpression (Onai et al., 2006) and by 
transgenic mice in which Flt3L overexpression leads to a robust 
expansion of DCs, lymphocytes, and myeloid cells at the expense 
of erythrocytes and platelets (Tsapogas et al., 2014). Nonetheless, 
Flt3L administration does not increase in vivo DC output from 
early Flt3+ progenitors such as common lymphoid progenitors, 
common myeloid progenitors, or granulocyte-monocyte progen-
itors (Karsunky et al., 2003), and the continued presence of DCs 
in Flt3−/− and Flt3l−/− mice, albeit at reduced numbers, suggests 
that DC development can occur through some unidentified mech-
anism in the absence of this cytokine pathway. Thus, it remains 
unclear what specific role Flt3L plays in DC progenitor specifica-
tion and development, as well as whether any other cytokines can 
contribute to this process.
To address the apparent discrepancy in phenotypes between 
Flt3−/− and Flt3l−/− mice, we directly compared DC development 
in these strains over time. We confirmed that Flt3l−/− mice show a 
severe and persistent DC defect, whereas Flt3−/− mice have a less 
severe defect at all ages analyzed. However, we were unable to 
demonstrate activity for Flt3L on a second receptor as has been 
proposed. Instead, we found that DC progenitors developed nor-
mally without instructional cues from Flt3 signaling and, sur-
prisingly, that these progenitors could mature in Flt3−/− mice in 
response to macrophage colony–stimulating factor (M-CSF) and 
stem cell factor (SCF), ligands for other class III RTKs expressed 
by these cells. Deletion of Csf1r in Flt3−/− mice also led to a further 
reduction in DC development in a cell-intrinsic manner, indicat-
ing that this cytokine pathway was partially compensating for 
the loss of Flt3 in vivo. Although the expression of CSF1R and 
c-Kit was not altered in Flt3−/− progenitors, we found that these 
progenitors were more responsive to stimulation by M-CSF, sug-
gesting that the absence of Flt3 potentiates signaling by other 
class III RTKs. To test whether this effect was responsible for 
the discrepancy between Flt3−/− and Flt3l−/− mice, we generated 
Flt3−/−Flt3l−/− mice and found that the additional deletion of Flt3 
paradoxically restored DC numbers in Flt3l−/− mice. We conclude 
that multiple cytokine pathways can support the development of 
DCs, and that the discrepancy between Flt3−/− and Flt3l−/− mice is 
a result of the enhanced sensitivity of Flt3−/− BM progenitors to 
signaling by these alternative cytokines.
Results
Flt3l−/− mice have a more severe DC deficiency 
than Flt3−/− mice
The original studies that analyzed Flt3−/− and Flt3l−/− mice did not 
directly compare these strains at similar ages, so the previously 
noted phenotypic discrepancy may simply have been a result of 
mismatched comparisons (McKenna et al., 2000; Waskow et al., 
2008). We therefore examined matched sets of Flt3−/− and Flt3l−/− 
mice at both 2 and 8 wk of age (Figs. 1 and 2). We confirmed the 
previous report of severe reductions in the percentage (Fig. 1, C 
and E) and numbers (Fig. 1, D and F) of splenic cDCs and pDCs 
at 2 wk in both Flt3−/− and Flt3l−/− mice. We also found severe 
reductions in both populations in the skin-draining lymph nodes 
(SLNs; Fig. S1, B and C) and lungs (Fig. S1 G) of these strains. Even 
at this age, however, the defect in cDCs and pDCs was more severe 
in Flt3l−/− mice than in Flt3−/− mice in all organs analyzed. We 
also observed previously unrecognized heterozygous phenotypes 
in both Flt3+/− and Flt3l+/− mice compared with WT mice. Flt3l+/− 
mice showed a twofold reduction in DC numbers relative to WT 
mice, whereas, surprisingly, Flt3+/− mice had significantly more 
DCs than WT mice (Fig. 1, C–F).
In contrast, at 8 wk, Flt3−/− mice showed only a mild defi-
ciency in the percentage and number of splenic DCs, whereas 
Flt3l−/− mice continued having severely reduced DC populations 
compared with both WT and Flt3−/− mice (Fig. 2, A–F). Findings 
were similar for cDCs and pDCs in the SLNs (Fig. S1, D and E) 
and for cDCs in the lungs (Fig. S1 H). Heterozygous phenotypes 
were again observed at 8 wk, with Flt3l+/− mice showing a twofold 
reduction in DCs compared with WT mice and Flt3+/− mice hav-
ing consistently greater numbers of DCs compared with WT mice 
(Fig. 2, A–F). In summary, the more severe DC defect in Flt3l−/− 
mice compared with Flt3−/− mice appears to be an inherent dif-
ference between these strains.
Flt3L does not support DC development from Flt3−/− BM or 
in Flt3−/− mice
To explain the discrepancy between Flt3−/− and Flt3l−/− mice, 
some have suggested that Flt3L could support DC development 
in Flt3−/− mice by acting on a second receptor, thus explaining 
the less severe phenotype of Flt3−/− mice (Nagasawa, 2006; Helft 
et al., 2010; Satpathy et al., 2011; Moore and Anderson, 2013; 
Tsapogas et al., 2017). To test for evidence of a second Flt3L 
receptor, we cultured WT and Flt3−/− BM in vitro with Flt3L and 
assessed DC development, hypothesizing that Flt3L could bind 
to its second receptor in Flt3−/− BM and generate DCs. How-
ever, although Flt3L supported robust DC development from 
WT BM, it did not generate DCs from Flt3−/− BM (Fig. 3, A–E). 
Thus, in vitro, we were unable to provide evidence for a second 
receptor responding to Flt3L. We next administered Flt3L in vivo 
(Fig. 3, F–J). Flt3L administration to WT mice caused a signifi-
cant increase in the percentage and numbers of splenic DCs, as 
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in Flt3−/− mice (Fig. 3, F–J). In summary, we find no evidence for 
actions of Flt3L on a second receptor.
Because DCs in Flt3−/− mice appeared to arise independently of 
Flt3L, we wondered whether they were developmentally or func-
tionally impaired. We therefore examined the transcriptional 
profile of splenic cDC1s and cDC2s from WT and Flt3−/− mice 
using gene expression microarrays. We found no substantial 
changes in gene expression in either cDC subset, with the only 
annotated transcript showing a greater-than fourfold change 
being Flt3 itself (Fig.  4, A and B). In addition, we found that 
Flt3−/− cDC1s were able to cross-present cell-associated and solu-
ble antigen to CD8 T cells as efficiently as WT cDC1s (Fig. 4, C–E), 
suggesting they were functionally similar. We next examined the 
transcriptional profile of splenic pDCs from WT and Flt3−/− mice 
Figure 1. Flt3l−/− mice have a more severe DC deficiency than Flt3−/− mice at two weeks of age. (A and B) Splenocytes from mice of the indicated geno-
types at 2-wk of age were analyzed by flow cytometry for DC populations. Shown are representative two-color histograms of live cells. Numbers specify the 
percentage of cells within the indicated gates. (C–F) Summary data for the percentage (C) and number (D) of splenic cDCs and the percentage (E) and number 
(F) of splenic pDCs in mice of the indicated genotypes. Dots represent biological replicates; small horizontal lines indicate the mean. Data are pooled from seven 
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(Fig. 4 F). We again found only minor differences between these 
populations, with Flt3 being the only annotated transcript show-
ing a greater-than fourfold increase in expression in WT pDCs 
and with several genes encoding Igκ segments being more highly 
expressed in Flt3−/− pDCs. pDCs have been found to develop from 
both myeloid and lymphoid progenitors (Sathe et al., 2013), 
with pDCs derived from lymphoid progenitors showcasing rear-
rangements of D-J segments in the immunoglobulin genes. The 
increased expression of these genes encoding Igκ segments in 
Flt3−/− pDCs could therefore indicate that the pDCs in Flt3−/− mice 
preferentially arise from lymphoid rather than myeloid progeni-
tors. Other than these genes, we found that the expression of the 
vast majority of transcripts was similar between WT and Flt3−/− 
pDCs (Fig. 4 F). Finally, we stimulated WT and Flt3−/− pDCs with 
CpG oligodeoxynucleotides and found that both populations pro-
duced a comparable amount of IFN-α (Fig. 4 G). Together, these 
Figure 2. Flt3l−/− mice continue to have a more severe DC deficiency than Flt3−/− mice at eight weeks of age. (A and B) Splenocytes from mice of the 
indicated genotypes at 8-wk of age were analyzed by flow cytometry for DC populations. Shown are representative two-color histograms of live cells. Numbers 
specify the percentage of cells within the indicated gates. (C–F) Summary data for the percentage (C) and number (D) of splenic cDCs and the percentage (E) 
and number (F) of splenic pDCs in mice of the indicated genotypes. Dots represent biological replicates; small horizontal lines indicate the mean. Data are 
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Figure 3. Flt3L fails to generate DCs in Flt3−/− mice. (A–E) BM cells from WT (Flt3+/+) or Flt3−/− mice were treated with vehicle or Flt3L and cultured for 9 
d. Live cells were subsequently analyzed by flow cytometry for DC populations. (A) Shown are representative two-color histograms of live cells pregated as 
indicated above the plots. Numbers specify the percentage of cells within the indicated gates. (B–E) Summary data for the percentage (B) and number (C) of 
cDCs in each culture and for the percentage (D) and number (E) of pDCs in each culture. Dots represent biological replicates; small horizontal lines indicate 
the mean. Data are pooled from three independent experiments (n = 4 mice per genotype). (F–J) WT (Flt3+/+) and Flt3−/− mice were administered vehicle or 
Flt3L subcutaneously for 8 d and splenocytes were subsequently analyzed by flow cytometry on day 9 for DC populations. (F) Shown are representative two-
color histograms of live cells. Numbers specify the percentage of cells within the indicated gates. (G–J) Summary data for the percentage (G) and number (H) 
of splenic cDCs and the percentage (I) and number (J) of splenic pDCs. Dots represent biological replicates; small horizontal lines indicate the mean. Data are 
pooled from two independent experiments (n = 5 mice per group). ns, not significant (P > 0.05); *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 using 
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results suggest that the DCs in Flt3−/− mice are transcriptionally 
and functionally similar to WT DCs, implying that Flt3 signaling 
is not essential for generating functional DCs.
Committed DC progenitors develop in Flt3−/− BM and can 
mature in response to M-CSF and SCF
We next considered whether Flt3−/− DCs could be maturing in 
response to alternative cytokines. The receptors for M-CSF 
(CD115/CSF1R) and for SCF (CD117/c-Kit) are both expressed by 
the MDP and CDP (Liu et al., 2009), suggesting that these cyto-
kines could act on these progenitors, and M-CSF has also been 
reported to support the development of some DC subsets in vitro 
(Fancke et al., 2008). To help identify cDCs in the Flt3−/− back-
ground, we crossed Flt3−/− mice to Zbtb46GFP/+ mice to generate 
Flt3−/−Zbtb46GFP/+ mice, in which we could use Zbtb46GFP expres-
sion to distinguish cDCs from other lineages (Meredith et al., 
2012; Satpathy et al., 2012; Wu et al., 2016). We then cultured 
bulk BM from WT (Flt3+/+Zbtb46GFP/+), Flt3+/−Zbtb46GFP/+, and 
Flt3−/−Zbtb46GFP/+ mice with Flt3L, M-CSF, or SCF and assessed 
DC development. Surprisingly, we found that all three cytokines 
supported the development of cDC1s and cDC2s from WT and 
Flt3+/− BM, whereas M-CSF and SCF also supported cDC devel-
opment from Flt3−/− BM (Fig. 5, A and B). Notably, M-CSF and 
SCF generated a greater percentage (Fig. 5 B) and number (Fig. 
S2 A) of cDCs from Flt3−/− BM than from WT BM, suggesting that 
Flt3−/− BM may be more responsive to these cytokines than WT 
BM. Importantly, the cDCs generated in all cultures were uni-
formly positive for Zbtb46GFP expression (Fig. 5 A), confirming 
their identity as bona fide cDCs (Meredith et al., 2012; Satpathy 
et al., 2012; Wu et al., 2016).
To further characterize these cells and to identify any hetero-
geneity in the populations, we examined the expression of a vari-
ety of functional markers in cDCs from each culture condition. 
We found that the cDCs generated in response to each cytokine 
generally expressed similar levels of costimulatory molecules 
such as CD86, PD-L2, CD40, and CD205; surface markers such as 
CD24, CD172a, and CD11b; and DC-specific markers such as Flt3/
CD135 (the cDCs from Flt3L cultures expressed low levels of this 
receptor, potentially caused by down-regulation after exposure 
to Flt3L), CCR7, and CD117, and that they all expressed similarly 
low levels of macrophage markers such as CD115 and CD64 (Fig. 
S2 B). Thus, we concluded that the cDCs that mature in response 
to M-CSF and SCF are generally similar in phenotype to those 
that are generated by Flt3L. Finally, we found that Flt3L, M-CSF, 
and SCF could all support pDC development from WT BM and 
that M-CSF and SCF could also support pDC development from 
Flt3−/− BM (Fig. S3 A).
Because mature DCs could be generated from the BM of Flt3−/− 
mice, we wondered whether DC progenitor specification was 
occurring normally in these mice. Identifying the CDP relies on 
Flt3 expression (Onai et al., 2007) and is therefore not possible 
in Flt3−/− mice. However, two restricted cDC progenitors down-
stream of the CDP, pre-cDC1 and pre-cDC2, can be identified with 
Zbtb46GFP expression and additional markers without the need 
for Flt3 (Grajales-Reyes et al., 2015). We therefore analyzed BM 
from Flt3−/−Zbtb46GFP/+ mice to identify these progenitors and 
found normal frequencies of pre-cDC1s and pre-cDC2s compared 
with Flt3+/+Zbtb46GFP/+ mice (Fig.  5  C). As a control, BM from 
Irf8−/−Zbtb46GFP/+ mice lacked pre-cDC1s and had reduced pre-
cDC2s, as expected (Grajales-Reyes et al., 2015). Thus, cDC pro-
genitor specification appears to be independent of Flt3 signaling.
We next asked whether M-CSF and SCF could act directly 
on committed DC progenitors to support their maturation. To 
address this question, we sort purified WT CDPs, which express 
Flt3, CSF1R, and c-Kit, and cultured them with Flt3L, M-CSF, or 
SCF. These cytokines each supported development of the CDP into 
mature Zbtb46GFP-positive cDC1s and cDC2s (Fig. 6 A) as well as 
pDCs (Fig. S3 B). In addition, pre-cDC2s, which normally express 
CSF1R and Flt3, were isolated from Flt3+/+Zbtb46GFP/+ mice and 
Flt3−/−Zbtb46GFP/+ mice and cultured with Flt3L or M-CSF. As 
expected, Flt3L supported development of the pre-cDC2 into 
mature Zbtb46GFP-positive cDC2s from WT progenitors but not 
from Flt3−/− progenitors (Fig. 6 B). In contrast, M-CSF supported 
development of the pre-cDC2 into Zbtb46GFP-positive cDC2s 
from both WT and Flt3−/− progenitors (Fig. 6 B). When we ana-
lyzed cell divisions using cell proliferation dye tracing, we found 
that, when cultured with M-CSF, Flt3−/− pre-cDC2s proliferated 
more than WT pre-cDC2s (Fig. 6 C), again suggesting that Flt3−/− 
progenitors were more responsive to M-CSF than WT progen-
itors. Thus, our data suggest that specified DC progenitors that 
Figure 4. Flt3−/− DCs are transcriptionally and functionally similar to WT DCs. (A and B) Microarray analysis of gene expression in cDC1s (A) or cDC2s (B) 
from Flt3+/+ and Flt3−/− mice, presented as M-plots. Colors indicate higher (red) or lower (blue) expression in Flt3+/+ cells than in Flt3−/− cells. Annotated genes 
with a greater than fourfold change in expression are specified (n = 2 biological replicates per subset per genotype). (C) Sorted cDC subsets from Flt3+/+ or 
Flt3−/− mice were cultured for 3 d with CFSE-labeled OT-I cells and different doses of heat-killed LM-OVA (HKLM-OVA) and then assayed for OT-I proliferation 
(CFSE–CD44+). Summary data for the percentage of proliferated OT-I cells in cultures with cDC subsets from the indicated genotypes are shown. Data are pooled 
from two independent experiments (n = 4 mice per genotype). (D) Sorted cDC subsets from Flt3+/+ or Flt3−/− mice were cultured for 3 d with CFSE-labeled OT-I 
cells and different doses of soluble OVA as antigen and then assayed for OT-I proliferation (CFSE–CD44+). Summary data for the percentage of proliferated 
OT-I cells in cultures with cDC subsets from the indicated genotypes are shown. Data are pooled from two independent experiments (n = 4 mice per geno-
type). (E) Sorted cDC subsets from Flt3+/+ or Flt3−/− mice were incubated with soluble OVA, washed, and then different numbers of cDCs were cultured with 
CFSE-labeled OT-I cells for 3 d after which OT-I proliferation was assayed. Summary data for the percentage of proliferated OT-I cells in cultures with the cDC 
subsets from the indicated genotypes are shown. Dots represent the mean; error bars represent the SEM. Data are pooled from two independent experiments 
(n = 4 mice per genotype). (F) Microarray analysis of gene expression in pDCs from Flt3+/+ and Flt3−/− mice, presented as M-plots. Colors indicate higher (red) 
or lower (blue) expression in Flt3+/+ cells than in Flt3−/− cells. Annotated genes with a greater than fourfold change in expression are specified (n = 2 biological 
replicates per subset per genotype). (G) Sorted pDCs from Flt3+/+ or Flt3−/− mice were stimulated with vehicle or CpG-A oligodeoxynucleotides overnight and 
then the cell supernatant was analyzed for IFN-α production. Summary data for the quantity of IFN-α produced by pDCs of the indicated genotypes are shown. 
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Figure 5. Flt3−/− BM generates mature DCs in response to M-CSF or SCF and contains committed DC progenitors. (A and B) BM cells from mice of the 
indicated genotypes were treated with vehicle, Flt3L, M-CSF, or SCF and cultured for 7 d. Live cells were subsequently analyzed by flow cytometry for devel-
opment of DCs. (A) Shown are representative two-color histograms of live cells pregated as indicated above the plots and one-color histograms of Zbtb46GFP 
expression in cells of the indicated subtype. Numbers represent the percentage of cells within the indicated gates. (B) Summary data for the percentage of 
cDCs in each culture. Dots represent biological replicates; small horizontal lines indicate the mean. Data are pooled from five independent experiments (n = 
5–7 mice per genotype). (C) BM cells from mice of the indicated genotypes were analyzed by flow cytometry for DC progenitor populations; lineage markers 
include CD3, CD19, CD105, Ter119, and Ly-6G. Representative two-color histograms are shown of live cells pregated as indicated above the plots. Numbers 
specify the percentage of cells within the indicated gates. Data are representative of four independent experiments (n = 7 mice per genotype). ns, not significant 
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develop in the presence or absence of Flt3 signaling can mature 
in response to cytokines other than Flt3L.
DC development in Flt3−/− mice is substantially 
dependent on CSF1R
To determine whether M-CSF supported the in vivo DC develop-
ment observed in Flt3−/− mice, we deleted Csf1r (Li et al., 2006) 
in WT and Flt3−/− mice using a tamoxifen-inducible Cre recombi-
nase (Ventura et al., 2007). Deletion of Csf1r in WT mice caused 
a small decrease in splenic cDC percentage and numbers, con-
sistent with a previous study describing a minor role for CSF1R 
in cDC homeostasis (Fig. 7, A, C, and D; Ginhoux et al., 2009). 
In contrast, deletion of Csf1r in Flt3−/− mice led to a substantial 
reduction in cDCs (Fig. 7, B–D), confirming that cDCs develop-
ing in Flt3−/− mice arise in part through the actions of CSF1R. 
pDC development, however, was unaffected by the additional 
deletion of Csf1r (Fig. 7, E and F), consistent with prior studies 
showing that pDC progenitors are enriched in the CSF1R– fraction 
of BM progenitors (Onai et al., 2013) and that almost all pDCs 
are derived from an IL-7R+ progenitor (Schlenner et al., 2010). 
Our gene expression data had also indicated that the pDCs in 
Flt3−/− mice may be preferentially developing from lymphoid 
progenitors (Fig. 4 F), which, combined with the lack of a role for 
CSF1R, suggests that the pDCs in Flt3−/− mice may be developing 
in response to compensatory signaling from a receptor expressed 
on lymphoid progenitors such as IL-7R. In summary, a substan-
tial portion of cDC but not pDC development in Flt3−/− mice is 
dependent on CSF1R.
To test whether this action of CSF1R was cell-intrinsic to DC 
progenitors, we generated mixed BM chimeras with a 50:50 mix 
of Flt3−/− BM and either Flt3−/−Csf1rf/fR26+/+ BM (CreERT2–) or 
Flt3−/−Csf1rf/fR26CreERT2/+ BM (CreERT2+). Although all BM pro-
genitors in these chimeras were deficient in Flt3, tamoxifen 
treatment led to the additional deletion of CSF1R in half of the 
BM cells in CreERT2+ chimeras but not in CreERT2– chimeras 
(Fig. 7 G). Thus, we could directly compare the DC potential of 
progenitors lacking both Flt3 and CSF1R with progenitors lack-
ing only Flt3. In CreERT2+ chimeras, cDCs preferentially devel-
oped from Flt3−/− BM cells, rather than from Flt3−/−Csf1r−/− BM, 
whereas in CreERT2– chimeras there was no skew in DC devel-
opment between Flt3−/− and Flt3−/−Csf1rf/fR26+/+ BM (Fig.  7, G 
and H). This result suggests that the contribution of CSF1R to DC 
development in Flt3−/− progenitors is cell-intrinsic.
Flt3−/− progenitors express normal levels of CSF1R and c-Kit 
but display enhanced signaling from these receptors
Because M-CSF and SCF could support DC development inde-
pendently of Flt3, we wondered whether the discrepancy 
between Flt3−/− and Flt3l−/− mice might be a result of differences 
in the expression or signaling of CSF1R or c-Kit in these differ-
ent strains. First, we found no differences in surface expres-
sion of CSF1R or c-Kit in total BM isolated from WT, Flt3−/−, and 
Flt3l−/− mice (Fig. 8 A). We next sought to quantify the expres-
sion of these receptors in early DC progenitors, but because Flt3 
is required to identify the MDP and CDP (Onai et al., 2007), we 
could not analyze these progenitors in Flt3−/− mice. We therefore 
generated Flt3l−/−Zbtb46GFP/+ mice to identify the pre-cDC1 and 
pre-cDC2 in Flt3l−/− mice, which would allow us to compare these 
progenitors in WT, Flt3−/−, and Flt3l−/− mice. We found that both 
progenitors still developed in Flt3l−/− mice, but were substan-
tially fewer in number relative to WT and Flt3−/− mice (Fig. S4 
A). This was similar to the reported deficiency in MDPs and CDPs 
in Flt3l−/− mice (Kingston et al., 2009), suggesting that all DC pro-
genitors are affected by the loss of Flt3L. We found, however, that 
the expression of CSF1R and c-Kit was not different in pre-cDC1s 
or pre-cDC2s from Flt3−/− or Flt3l−/− mice relative to WT mice 
(Fig. 8 B), again suggesting that changes in receptor expression 
did not explain the differences between these strains. Finally, we 
sought to determine the expression of these receptors in mature 
splenic cDCs from these strains, but as collagenase digestion of 
the spleen impairs detection of these receptors by FACS (Merad 
et al., 2013), we instead used gene expression microarrays. We 
found no differences in Csf1r or Kit gene expression in splenic 
cDC1s or cDC2s from WT, Flt3−/−, and Flt3l−/− mice (Fig. 8 C). Thus, 
we excluded differences in receptor expression as a cause of the 
discrepancy between Flt3−/− and Flt3l−/− mice.
The in vitro DC development supported by M-CSF and SCF 
was greater in Flt3−/− BM relative to WT BM (Fig. 5 B), and Flt3−/− 
pre-cDC2s proliferated more than WT pre-cDC2s in response to 
M-CSF (Fig. 6 C), suggesting there was some alteration in recep-
tor sensitivity between WT and Flt3−/− mice. Flt3, CSF1R, and c-Kit 
are all class III RTKs that share signaling adaptor molecules such 
as Shc and Grb2 (Dosil et al., 1993; Rottapel et al., 1994; Verstraete 
and Savvides, 2012; Tsapogas et al., 2017). We wondered whether 
the loss of Flt3 might increase the availability of these adaptors 
and thereby enhance signaling from CSF1R or c-Kit. To test this, 
we quantified the sensitivity of CSF1R signaling in BM progeni-
tors. We treated serum-starved BM cells from Flt3+/+, Flt3+/−, or 
Flt3−/− mice with varying concentrations of M-CSF and quanti-
fied phosphorylation of the MAPK pathway protein Erk1/2 in 
pre-cDC2s (Fig.  9 A). We examined this progenitor because it 
expresses CSF1R and can be identified independently of Flt3 by 
using Zbtb46-GFP expression (Grajales-Reyes et al., 2015). Over 
a range of concentrations, both the percentage of pre-cDC2s 
responding to M-CSF and the intensity of signaling in each pro-
genitor was greater in Flt3−/− pre-cDC2s compared with Flt3+/+ 
pre-cDC2 cells, with Flt3+/− pre-cDC2s displaying an interme-
diate phenotype (Fig. 9, A and B). Thus, the loss of Flt3 directly 
enhances the sensitivity and strength of CSF1R signaling in 
response to M-CSF. Importantly, no differences were observed 
in M-CSF signaling sensitivity in Flt3l−/− pre-cDC2s relative to 
WT for most concentrations of M-CSF (Fig. S4 B), indicating that 
the increased sensitivity to M-CSF was specific to Flt3−/− mice 
and could possibly explain the difference between these mice and 
Flt3l−/− mice.
Deletion of Flt3 in Flt3l−/− mice paradoxically 
restores DC development
The increased sensitivity of CSF1R signaling in Flt3−/− DC pro-
genitors could explain the discrepancy in DC numbers between 
Flt3−/− and Flt3l−/− mice. Flt3−/− DC progenitors could respond 
more robustly to alternative cytokines such as M-CSF or SCF 
and thus develop greater numbers of DCs. This hypothesis pre-
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occur regardless of the presence of Flt3L and thus that loss of 
Flt3 in the Flt3l−/− background should enhance CSF1R signaling 
and potentially increase DC numbers. To test this hypothesis, we 
crossed Flt3−/− and Flt3l−/− mice to generate Flt3−/−Flt3l−/− mice 
and characterized DC development in the resulting littermates. 
We first found that, unlike Flt3+/− mice, Flt3+/−Flt3l+/− mice had 
mildly reduced DC numbers (Fig. 10, A–E). This suggests that the 
decrease in DCs we found in Flt3l+/− mice (Figs. 1 and 2) was more 
impactful than the increase in DCs observed in Flt3+/− mice (Figs. 
1 and 2) and that together these alleles resulted in a net decrease 
in DC numbers in Flt3+/−Flt3l+/− mice. But most surprisingly, we 
found that Flt3−/−Flt3l−/− mice had an increase in splenic cDC and 
pDC percentage and numbers relative to Flt3l−/− mice and were 
indistinguishable from Flt3−/− mice (Fig. 10, A–E). This increase 
was also observed in cDCs and pDCs in the SLNs (Fig. S5, A and B), 
as well as in cDCs in the lung (Fig. S5 C). Thus, paradoxically, the 
severe DC deficiency observed in Flt3l−/− mice was rescued by the 
additional loss of Flt3. These results suggest that the discrepancy 
observed between Flt3−/− and Flt3l−/− mice is, at least in part, a 
result of an inherent alteration in the response of DC progenitors 
to alternative cytokines secondary to the loss of Flt3.
Discussion
In this study, we have identified the previously unknown cyto-
kine pathways that support the residual DC development seen in 
Flt3−/− and Flt3l−/− mice, and we provide an explanation for the 
puzzling discrepancy in phenotypes between these two strains. 
Although both Flt3 and Flt3L have long been recognized to play 
major roles in DC homeostasis (McKenna et al., 2000; Waskow 
et al., 2008), it had remained unclear through what mechanism 
DCs continue to arise in mice deficient in either of these factors. 
We have demonstrated here that M-CSF and SCF, two cytokines 
whose receptors are expressed in DC progenitors, are capable 
of generating DCs from both WT and Flt3−/− BM progenitors in 
vitro. We also found that a substantial fraction of the DCs that 
arise in vivo in Flt3−/− mice are dependent on CSF1R for their 
development, with c-Kit possibly responsible for generating the 
remainder of the DCs.
These findings, along with the continued presence of com-
mitted DC progenitors in Flt3−/− mice, suggest that DC lineage 
commitment may not require the Flt3 pathway and that multi-
ple cytokines can provide the supportive signals necessary for 
the maturation of these progenitors. Furthermore, the DCs that 
develop in Flt3−/− mice were functional and had transcriptional 
profiles indistinguishable from WT DCs, suggesting that the 
actions of Flt3L in DC development can be compensated entirely 
by other cytokines. Though we had originally hypothesized that 
WT DCs would possess a gene signature indicative of their mat-
uration in response to Flt3 signaling, that we did not see such a 
signature or a corresponding gene signature suggestive of M-CSF 
signaling in the Flt3−/− DCs suggests that these cytokines may not 
impose any long-lasting genetic instruction upon mature DCs, 
but instead simply support their development. DCs are there-
fore another example of a lineage that continues to develop and 
function in the absence of its principal growth factor, similar 
to granulocytes (Lieschke et al., 1994), erythrocytes (Wu et al., 
1995), and lymphocytes (Peschon et al., 1994; von Freeden-Jeffry 
et al., 1995). Findings such as these help elucidate the precise role 
of cytokines in hematopoietic lineage commitment and suggest 
at least some level of promiscuity between cytokine pathways 
and cell types.
Loss of a receptor and its unique ligand would generally be 
expected to produce the same phenotype. However, our direct 
comparison of Flt3−/− and Flt3l−/− mice clearly documents that 
loss of the ligand causes a more severe and durable DC defi-
ciency than loss of the receptor. We were unable to find evidence 
to support previous suggestions that Flt3L might be acting at a 
second receptor beside Flt3 (Nagasawa, 2006; Helft et al., 2010; 
Satpathy et al., 2011; Moore and Anderson, 2013; Tsapogas et al., 
2017). Instead, we found that Flt3−/− DC progenitors exhibit an 
intrinsic alteration in the sensitivity of other cytokine receptors 
compared with WT progenitors. This may allow compensatory 
cytokines such as M-CSF and SCF to generate a greater number 
of DCs in Flt3−/− mice relative to WT or Flt3l−/− mice. We there-
fore predicted, and then validated, the paradoxical result that the 
severe DC defect in Flt3l−/− mice is actually restored upon deletion 
of Flt3. Thus, it appears that the discrepancy in DC development 
between Flt3−/− and Flt3l−/− mice arises secondary to a phenotype 
of increased sensitivity of Flt3−/− DC progenitors to alternative 
cytokines. It is possible that a similar increase in sensitivity to 
IL-7 in early B cell progenitors could explain the previously iden-
tified discrepancy in B cell development between these strains 
(Nagasawa, 2006).
The increased sensitivity of Flt3+/− progenitors to M-CSF 
(Fig.  9) might also explain the increased DC numbers we 
observed in Flt3+/− mice (Figs. 1 and 2). Flt3+/− BM produced DCs 
in response to Flt3L as well as to M-CSF (Fig. 5 B), so the increased 
Figure 6. Committed DC progenitors can mature in response to M-CSF and SCF. (A) CDPs (Lin–CD117intCD135+CD115+CD11c–MHC II–) were sorted from 
Zbtb46GFP/+ mice and cultured with vehicle, Flt3L, M-CSF, or SCF for 5 d. Cells were subsequently analyzed by flow cytometry for development of DCs. Shown 
are representative two-color histograms of live cells pregated as indicated above the plots and one-color histograms of Zbtb46GFP expression. Numbers specify 
the percentage of cells within the indicated gates. Data are representative of three independent experiments (sorted cells from three to five mice were pooled 
in each individual experiment). (B) Pre-cDC2s (Lin–CD115+CD11c+MHC II–Zbtb46+) were sorted from Flt3+/+Zbtb46GFP/+ or Flt3−/−Zbtb46GFP/+ mice as indicated 
and cultured with vehicle, Flt3L, or M-CSF for 5 d. Cells were subsequently analyzed by flow cytometry for development of DCs. Shown are representative 
two-color histograms of live cells pregated as indicated above the plots and one-color histograms of Zbtb46GFP expression in cells of the indicated subtype. 
Numbers specify the percentage of cells within the indicated gates. Data are representative of three independent experiments (sorted cells from three to five 
mice per genotype were pooled in each individual experiment). (C) Pre-cDC2s were sorted from Flt3+/+Zbtb46GFP/+ or Flt3−/−Zbtb46GFP/+ mice, labeled with Cell 
Proliferation Dye (CPD), and cultured with M-CSF for 5 d. Cells were subsequently analyzed by flow cytometry for dilution of CPD to determine the number of 
divisions they underwent. Shown is a representative one-color histogram of CPD levels and the percentage of cells at each division. Data are representative of 
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DC numbers seen in Flt3+/− mice conceivably results from the 
combination of both normal Flt3L signaling and enhanced 
M-CSF signaling contributing to DC development in these mice. 
In contrast, in Flt3−/− mice only enhanced M-CSF signaling, but 
not Flt3L signaling, contributes to DC development, and these 
mice therefore have fewer DCs despite their even greater sensi-
tivity to M-CSF.
We have not explored the biochemical basis for the altered 
sensitivity observed in Flt3−/− DC progenitors. Conceivably, loss 
of Flt3 increases the availability of shared signaling adaptor pro-
teins such as Shc and Grb2 used by other class III RTKs (Dosil 
et al., 1993; Rottapel et al., 1994; Verstraete and Savvides, 2012; 
Tsapogas et al., 2017). The increased availability of these adaptors 
could then allow other receptors acting through them to activate 
downstream pathways more quickly and potently. Although the 
exact mechanism remains to be uncovered, our results highlight 
the potential for unintended consequences that may result when 
manipulating the levels of signaling molecules in complex bio-
logical systems. The deletion of Flt3 appears to have ramifica-
tions beyond simply the loss of signaling by this receptor, and the 
study of other receptor knockout mice may have similar caveats 
that should be considered.
Materials and methods
Mice
All mice were bred and maintained on the C57BL/6 background 
in a specific pathogen-free animal facility following institu-
tional guidelines and with protocols approved by the Animal 
Studies Committee at Washington University in St. Louis. 
Unless otherwise specified, experiments were performed with 
mice 6- to 10-wk of age. No differences were observed between 
male and female mice in any assays and so mice of both gen-
ders were used throughout this study. Within individual exper-
iments, mice used were age- and sex-matched littermates 
whenever possible.
Flt3−/− mice (Mackarehtschian et al., 1995) were a gift from 
E. Camilla Forsberg (University of California, Santa Cruz, Santa 
Cruz, CA). Zbtb46GFP/+ mice have been previously described 
(Satpathy et al., 2012; Grajales-Reyes et al., 2015). The follow-
ing mice were purchased from The Jackson Laboratory: Flt3l−/− 
(C57BL/6-Flt3ltm1Imx/TacMmjax), CD45.1+ (B6.SJL-Ptprca 
Pepcb/BoyJ), OT-I (C57BL/6-Tg(TcraTcrb)1100Mjb/J), Csf1rf/f 
(B6.Cg-Csf1rtm1.2Jwp/J), and R26CreERT2/+ (B6.129-Gt(ROSA)26 
Sortm1(cre/ERT2)Tyj/J).
DC preparation
Lymphoid and nonlymphoid organ DCs were harvested and pre-
pared as described previously (Satpathy et al., 2012). In brief, 
spleens and SLNs (inguinal, axillary, and brachial) were minced 
and digested in 5 ml IMDM + 10% FCS (cIMDM) with 250 µg/ml 
collagenase B (Roche) and 30 U/ml DNase I (Sigma-Aldrich) for 
45 min at 37°C with stirring. Lungs were minced and digested in 
5 ml of cIMDM with 4 mg/ml collagenase D (Roche) and 30 U/
ml DNase I (Sigma-Aldrich) for 1.5 h at 37°C with stirring. After 
digestion, cell suspensions from all organs were passed through 
70-µm strainers and red blood cells were then lysed with ammo-
nium chloride-potassium bicarbonate lysis buffer. Cells were 
counted with a Vi-CELL analyzer (Beckman Coulter) and 3–5 × 
106 cells were used per antibody-staining reaction.
For experiments requiring sorting of splenic cDC subsets, 
cDCs were first enriched from total spleen cells with CD11c 
microbeads (Miltenyi Biotec). cDCs were then sorted on a flow 
cytometer (FAC SAria Fusion; BD Biosciences). cDC1s were sorted 
as CD11c+MHC-II+CD24+CD172a–F4/80–, and cDC2s were sorted 
as CD11c+MHC II+CD24–CD172a+F4/80–. Sort purity of >95% was 
confirmed by post-sort analysis before cells were used for fur-
ther experiments.
For experiments requiring sorting of splenic pDC subsets, 
spleen cells were first depleted of CD3-, B220-, and Ly6G-ex-
pressing cells by staining with the corresponding biotinylated 
antibodies followed by depletion with MagniSort Streptavidin 
Negative Selection beads (Thermo Fisher). pDCs were then sorted 
on a FAC SAria Fusion flow cytometer as B220+CD317+. Sort purity 
of >95% was confirmed by post-sort analysis before cells were 
used for further experiments.
Antibodies and flow cytometry
Samples were stained at 4°C in MACS buffer (DPBS + 0.5% BSA + 
2 mM EDTA) in the presence of Fc block (2.4G2; BD Biosciences). 
The following antibodies were purchased from BD Biosciences: 
CD8α V450 (53-6.7); CD11b PE (M1/70); CD19 Biotin (1D3); CD44 
APC-Cy7 (IM7); CD45R Alexa Fluor 488; V450 (RA3-6B2); CD45.2 
PerCP-Cy5.5 (104); CD64 Alexa Fluor 647 (X54-5/7.1); CD103 
BV421 (M290); CD117 BUV395 (2B8); CD127 BV421 (SB/199); CD135 
PE-CF594 (A2F10.1); Ly-6C Alexa Fluor 700 (AL-21); and I-A/I-E 
V500 (M5/114.15.2). From eBioscience: CD11c PE (N418); CD44 
Figure 7. cDC development in Flt3−/− mice is dependent on CSF1R. (A–F) Mice of the indicated genotypes were treated with tamoxifen to delete Csf1r. After 
treatment, splenocytes were analyzed by flow cytometry for DC populations. (A and B) Shown are representative two-color histograms of live cells. Numbers 
specify the percentage of cells within the indicated gates. (C–F) Summary data of the percentage (C) and number (D) of splenic cDCs and for the percentage 
(E) and number (F) of splenic pDCs in mice of the indicated genotypes. Dots represent biological replicates; small horizontal lines indicate the mean. Data 
are pooled from seven independent experiments. (n = 3–7 mice per genotype). (G and H) WT CD45.1+ mice were lethally irradiated and reconstituted with 
Flt3−/− CD45.1+:Flt3−/−Csf1rf/fR26+/+CD45.2+ BM at a 1:1 ratio (CreERT2–) or Flt3−/−CD45.1+:Flt3−/−Csf1rf/fR26CreERT2/+CD45.2+ BM at a 1:1 ratio (CreERT2+). After 
reconstitution and tamoxifen treatment to delete Csf1r, spleens and BM were analyzed by flow cytometry. (G) Shown are representative two-color histograms 
(pregating, above plots; splenic B cells, B220+CD24+; splenic cDCs, CD11c+MHC II+; BM CSF1R+ cells, CD115+). Numbers specify the percentage of cells within the 
indicated gates. (H) Summary data of the chimerism ratio of splenic cDCs presented as the ratio of CD45.1+ to CD45.2+ cDCs normalized to the ratio of CD45.1+ 
to CD45.2+ B cells within the same mouse. Dots represent individual mice; small horizontal lines indicate the mean. Data are pooled from four independent 
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APC (IM7); CD105 Biotin (MJ7/18); CD117 PE/Cy7 (2B8); CD172a 
PerCP-eFluor 710 (P84); CD317 APC (eBio927); and F4/80 APC-
eFluor 780 (BM8). From Invitrogen: TCR Vα2 PE (B20.1) and 
CD172a PerCP-eFluor 710 (P84). From Tonbo Biosciences: CD3e 
Biotin (145-2C11); CD11c APC-Cy7 (N418); CD45.1 PE-Cy7 (A20); 
and I-A/I-E V450 (M5/114.15.2). From BioLegend: CD4 APC (RM4-
5); CD24 PE/Cy7 (M1/69); CD45.1 BV605 (A20); CD45.2 Alexa 
Fluor 700 (104); CD115 BV711 (ASF98); Ly-6G Biotin (1A8); GFP 
Alexa Fluor 488 (FM264G); Siglec H PE (551); Ter-119 Biotin (TER-
119); TCR Vα2 PE; and PerCP-Cy5.5 (B20.1). From Cell Signaling: 
P-p44/42 MAPK (Erk1/2) (T202/Y204) PE (197G2). In general, all 
antibodies were used at a dilution of 1:200 unless specified oth-
erwise by the manufacturer. Cells were analyzed on a FAC SCanto 
II analyzer or FAC SAria Fusion. Data were analyzed with FlowJo 
software (TreeStar).
BM isolation and cell culture
BM was harvested from the femur, tibia, and pelvis. Bones were 
fragmented by mortar and pestle in MACS buffer, and debris was 
removed by passing cells through a 70-µm strainer. Red blood cells 
were subsequently lysed with ammonium chloride-potassium 
bicarbonate lysis buffer. Cells were counted on a Vi-CELL ana-
lyzer (Beckman Coulter), and 3–5 × 106 cells were stained for 
analysis. For Flt3L culture experiments, whole BM (8 × 106 cells in 
4 ml cIMDM) was cultured at 37°C with 100 ng/ml Flt3L (Pepro-
tech) or equivalent volume PBS (vehicle) for 9 d. For comparative 
cytokine culture experiments, whole BM (6 × 106 cells in 4 ml of 
cIMDM) was cultured at 37°C with 100 ng/ml Flt3L (Peprotech), 
20 ng/ml M-CSF (Peprotech), 50 ng/ml SCF (Peprotech), or 
equivalent volume PBS (vehicle) for 7 d. For all culture experi-
ments, loosely adherent and suspension cells were harvested by 
gentle pipetting at the indicated time point and stained with fluo- 
rescent antibodies for analysis by flow cytometry.
In vivo Flt3L administration
Flt3+/+ or Flt3−/− mice were injected subcutaneously with sterile 
saline (vehicle) or 10 µg of purified Flt3L-Fc fusion protein (gen-
erated in-house) daily for 8 d and analyzed on the following day.
Expression microarray analysis
Total RNA was extracted from sorted splenic DCs with an RNAque-
ous-Micro kit (Ambion), amplified with an Ovation Pico WTA 
Figure 8. Flt3−/− and Flt3l−/− BM progenitors and cDCs express normal levels of CSF1R and c-Kit. (A) BM cells from mice of the indicated genotypes were 
analyzed by flow cytometry for cytokine receptor expression. Representative two-color histograms of live cells are shown. Numbers specify the percentage of 
cells within the indicated gates. Data are representative of at least three independent experiments (n = 4–7 mice per genotype). (B) Pre-cDC1s and pre-cDC2s 
from mice of the indicated genotypes were analyzed by flow cytometry for cytokine receptor expression levels. Representative one-color histograms of each 
receptor are shown. Data are representative of three independent experiments (n = 3–7 mice per genotype). (C) Expression of the indicated genes in splenic 
cDC1s and cDC2s from mice of the indicated genotypes was determined by gene expression microarray analysis. Dots represent biological replicates (n = 2 
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System (NuGEN), and hybridized to Mouse Gene 1.0 ST arrays 
(Affymetrix). Expression values were analyzed after robust mul-
tiarray average summarization and quantile normalization using 
ArrayStar 4 software (DNA STAR). All gene expression microar-
ray data have been deposited in the NCBI Gene Expression Omni-
bus database with accession nos. GSE110789 and GSE110790.
Antigen presentation assays
In vitro cell-associated cross-presentation assays have been 
described previously (Kretzer et al., 2016). In brief, Listeria 
monocytogenes (LM)-OVA (a gift from H. Shen, University of 
Pennsylvania, Philadelphia, PA) was grown in brain–heart infu-
sion broth at 37°C for 6 h and then frozen overnight after dilution 
plating for titer enumeration. Bacteria were subsequently thawed 
and washed three times with PBS before heat killing at 80°C for 
1 h and then freezing at −80°C. OT-I T cells were meanwhile sorted 
from spleens of OT-I mice as B220–CD4–CD11c–CD45.1+CD8+Vα2+ 
and labeled with CFSE (eBioscience). Sort purity of >95% was 
confirmed by post-sort analysis before cells were used for assays. 
10,000 sorted splenic cDCs of the indicated subset from Flt3+/+ 
Figure 9. Flt3−/− DC progenitors display increased sensitivity to M-CSF. (A and B) Serum-starved BM from mice of the indicated genotypes was treated 
with M-CSF and assayed for phosphorylated Erk1/2 (pErk1/2) by intracellular flow cytometry. (A) Shown are representative one-color histograms of pErk1/2 
in pre-cDC2s stimulated with the indicated concentrations of M-CSF. Numbers in black indicate the percentage of cells within the gate, and numbers in red 
indicate the geometric MFI of pErk1/2 in the gated population. Data are representative of three independent experiments. (B) Summary data presented as the 
integrated MFI of pErk1/2 in pre-cDC2s from mice of the indicated genotypes stimulated with the indicated concentration of M-CSF. Dots indicate the mean 
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or Flt3−/− mice and 25,000 sorted CFSE-labeled OT-I T cells were 
incubated with various doses of heat-killed LM-OVA for 3 d at 
37°C. After incubation was complete, OT-I cells were assayed for 
CFSE dilution and CD44 expression.
For soluble OVA presentation assays, 10,000 sorted splenic 
cDCs of the indicated subset from Flt3+/+ or Flt3−/− mice and 
25,000 sorted CFSE-labeled OT-I T cells were incubated with 
the indicated concentration of OVA (Worthington Biochemical 
Figure 10. Deletion of Flt3 rescues the severe DC defect in Flt3l−/− mice. (A–E) Splenocytes from mice of the indicated genotypes at 8-wk of age were 
analyzed by flow cytometry for DC populations. (A) Shown are representative two-color histograms of live cells. Numbers specify the percentage of cells within 
the indicated gates. (B–E) Summary data for the percentage (B) and number (C) of splenic cDCs and the percentage (D) and number (E) of splenic pDCs in mice 
of the indicated genotypes. Dots represent biological replicates; small horizontal lines indicate the mean. Data are pooled from six independent experiments 
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Corporation) for 3 d at 37°C. After incubation was complete, OT-I 
T cells were assayed for CFSE dilution and CD44 expression.
Alternatively, sorted splenic cDCs of the indicated subset from 
Flt3+/+ or Flt3−/− mice were incubated with 0.1 mg/ml of soluble 
OVA (Worthington Biochemical Corporation) for 45 min at 37°C, 
washed three times with PBS, and then different numbers of 
cDCs were incubated with 25,000 sorted CFSE-labeled OT-I T 
cells for 3 d at 37°C. After incubation was complete, OT-I T cells 
were assayed for CFSE dilution and CD44 expression.
Type I interferon production from pDCs
25,000 sorted pDCs from Flt3+/+ or Flt3−/− mice were incubated 
overnight at 37°C in cIMDM with 100 ng/ml Flt3L plus either 6 
µg/ml of CpG-A oligodeoxynucleotides or the equivalent volume 
of PBS (vehicle). The next day cells were spun down and the 
supernatant was collected. IFN-α in the supernatant was mea-
sured using the PBL Verikine Mouse IFN Alpha All Subtype ELI SA 
kit, High Sensitivity (PBL Assay Science).
Progenitor sorting and culture
For sorting experiments, BM was isolated as described above 
and depleted of CD3-, CD19-, CD105-, Ter119-, and Ly6G-ex-
pressing cells by staining with the corresponding biotinylated 
antibodies followed by depletion with MagniSort Streptavi-
din Negative Selection beads (Thermo Fisher). The entirety 
of the remaining BM was then stained with fluorescent anti-
bodies before sorting. Gates used to define CDPs, pre-cDC1s, 
and pre-cDC2s were based on previous studies (Onai et al., 
2007; Grajales-Reyes et al., 2015). CDPs were identified as Lin–
CD117intCD135+CD115+CD11c–MHC II–; pre-cDC1s as Lin–CD117int 
CD11c+MHC IIintZbtb46-GFP+; and pre-cDC2s as Lin–CD117lo 
CD115+CD11c+MHC II–Zbtb46-GFP+. Lineage markers included 
CD3, CD19, CD105, Ter119, and Ly6G. A FAC SAria Fusion was 
used for sorting, and cells were sorted into cIMDM. Sort purity 
of >95% was confirmed by post-sort analysis before cells were 
used for further experiments. Sorted cells were cultured at 37°C 
in 200 µl total volume of cIMDM with 100 ng/ml Flt3L (Pepro-
tech), 20 ng/ml M-CSF (Peprotech), 50 ng/ml SCF (Peprotech), 
or equivalent volume of PBS (vehicle) for 5 d.
For cell proliferation studies, sorted pre-cDC2s were washed 
three times with PBS to remove serum and then incubated with 
10 µM of eBioscience Cell Proliferation Dye eFluor 450 (Thermo 
Fisher) at 37°C for 10 min. Reaction was quenched by the direct 
addition of FCS, and cells were washed three times with cIMDM. 
Cells were subsequently cultured at 37°C in 200 µl total volume 
of cIMDM with 20 ng/ml M-CSF (Peprotech) for 5 d.
Tamoxifen administration
Mice were orally gavaged with 4 mg tamoxifen (Sigma-Aldrich) 
dissolved in corn oil (Sigma-Aldrich) for an initial loading dose 
and then placed on tamoxifen citrate chow (Envigo) for 4–5 wk. 
Mice were given up to 2 d of regular chow per week if significant 
weight loss was observed. After treatment, mice were rested on 
regular chow for one week before analysis. Deletion of CSF1R in 
the BM was confirmed in all mice.
BM chimeras
BM cells from donor mice were collected as described above. To 
generate mixed BM chimeras, BM cells were isolated from mice 
of the appropriate genotypes, counted with a Vi-CELL analyzer 
(Beckman Coulter), and mixed at a ratio of 1:1 before transplanta-
tion. Recipient mice received a single dose of 1050 rads of whole-
body irradiation and then received a transplant of 10 × 106 total 
BM cells the following day. Mice were allowed to reconstitute for 
8–10 wk before further experiments or analyses were conducted.
BM progenitor cytokine stimulation
BM was isolated and lineage-depleted as described above. Lin– BM 
cells were then aliquoted at 106 cells per condition and serum-
starved in plain IMDM for 4 h at 37°C. After starvation, M-CSF was 
added at the indicated concentrations, and cells were incubated at 
37°C for 5 min for stimulation. Cells were then fixed for 15 min at 
room temperature by adding paraformaldehyde (Electron Micros-
copy Sciences) directly to cells to a final concentration of 2%. Cells 
were washed twice with MACS buffer and then permeabilized by 
adding ice-cold methanol directly to cells with gentle vortexing, 
followed by incubation at 4°C for 30 min. Cells were again washed 
twice with MACS buffer and then stained with fluorescent anti-
bodies against cell surface and intracellular antigens for 30 min at 
room temperature. Antibodies were previously tested individually 
to ensure their functionality in fixed and permeabilized cells. Flow 
cytometric analyses were then performed on stained cells. For 
analysis, we used integrated mean fluorescence intensity (iMFI), 
which combines frequency and MFI into a single measure of total 
functional response (Darrah et al., 2007; Shooshtari et al., 2010).
Statistical analysis
All statistical analyses were performed using Prism 7 (GraphPad 
Software). Statistical significance was evaluated using unpaired 
two-tailed Student's t test unless otherwise noted. Differences 
with P ≤ 0.05 were considered significant. n represents the num-
ber of biological replicates.
Online supplemental material
Fig. S1 shows the percentage of cDCs and pDCs in SLNs and 
lungs from the mice strains analyzed in Figs. 1 and 2. Fig. S2 
shows the number of cDCs developing from the in vitro cyto-
kine cultures from Fig. 5 and the expression of various costim-
ulatory molecules on these cDCs. Fig. S3 shows the development 
of pDCs from the in vitro cytokine cultures from Fig. 5 and the 
development of pDCs from sorted CDPs treated with various 
cytokines from Fig.  6. Fig. S4 shows the continued develop-
ment of pre-cDC1s and pre-cDC2s in Flt3l−/− mice and that the 
pre-cDC2s from Flt3l−/− mice are no more sensitive to M-CSF 
than the pre-cDC2s from Flt3l+/+ mice. Fig. S5 depicts that the 
deletion of Flt3 in Flt3l−/− mice reverses the severe DC defect in 
SLNs and lungs.
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